Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
45
|
pubmed:dateCreated |
1991-12-16
|
pubmed:abstractText |
A 42-year-old woman, found to have increased blood-lipid levels, developed hand-line xanthomas 3 months later. She also had an increased erythrocyte-sedimentation rate and a type lambda monoclonal IgM abnormality. In the course of the following 4 years the IgM concentration rose (from 5.8 to 12.3 g/l) steadily and synchronously with those of the triglycerides (from 147 to 391 mg/dl) and cholesterol (from 212 to 380 mg/dl). During the entire period of observation the ratio of VLDL cholesterol and triglyceride concentrations was elevated (greater than 0.4; normal: less than 0.3). Division of the lipoprotein fractions pointed to a type III hyperlipoproteinaemia. She also had an abnormality of lipid metabolism on the basis of a genetic defect (apolipoprotein-E2 homozygotism), which only manifested itself when an additional factor, IgM paraproteinaemia, was present. Paraproteins thus apparently interfered with the breakdown of the lipoproteins. Neither bezafibrate in increasing doses (200-800 mg daily) with low-fat diet nor administration of lovastatin (20 mg twice daily) together with nicotinic acid (500 mg twice daily) were adequate treatment for this form of auto-immune hyperlipidaemia.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Bezafibrate,
http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol,
http://linkedlifedata.com/resource/pubmed/chemical/Dietary Fats,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin lambda-Chains,
http://linkedlifedata.com/resource/pubmed/chemical/Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Lovastatin,
http://linkedlifedata.com/resource/pubmed/chemical/Niacin,
http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0012-0472
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
116
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1710-4
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:1935653-Adult,
pubmed-meshheading:1935653-Bezafibrate,
pubmed-meshheading:1935653-Cholesterol,
pubmed-meshheading:1935653-Dietary Fats,
pubmed-meshheading:1935653-Female,
pubmed-meshheading:1935653-Humans,
pubmed-meshheading:1935653-Hypergammaglobulinemia,
pubmed-meshheading:1935653-Hyperlipoproteinemia Type III,
pubmed-meshheading:1935653-Immunoglobulin M,
pubmed-meshheading:1935653-Immunoglobulin lambda-Chains,
pubmed-meshheading:1935653-Lipids,
pubmed-meshheading:1935653-Lovastatin,
pubmed-meshheading:1935653-Niacin,
pubmed-meshheading:1935653-Triglycerides
|
pubmed:year |
1991
|
pubmed:articleTitle |
[Type III hyperlipoproteinemia in monoclonal IgM gammopathy].
|
pubmed:affiliation |
Abteilung Innere Medizin III, Universität Heidelberg.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Case Reports
|